While earlier attempts were unsuccessful, with Glenmark running into huge losses, there seems to be growing consensus that the drugmaker’s R&D strategy makes it a different company. Perhaps even a valuable one.
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
Limited time offer $125 $99 for 1 year
For a country aspiring to be a superpower, with more than 250 million children in schools, India’s reluctance to participate in an international student assessment study is confounding.
In paving the way for Tesla to sell its cars in the country with reduced duties, India comes across as partisan and a country that can be bullied into acting against its own interests.
Last week, Larsen & Toubro chairman S. N. Subrahmanyan blamed welfare schemes for unavailability of labour. There are other factors in play too.